Golden Horseshoe Bioscience Network – Solutions for Life Golden Horseshoe Biosciences Network – Solutions for Life Darlene Homonko, PhD Executive Director.

Slides:



Advertisements
Similar presentations
Go-to-Market Strategy
Advertisements

COMMERCIALIZATION RESOURCES FOR RESEARCH AT UIC UIC Office of Technology Management and IllinoisVENTURES NANCY SULLIVAN CEO & Managing Director, IllinoisVENTURES.
IP Impact on Funding - Perspectives from the Field Castel Commercialization of Academic Research Key Considerations in Securing Funding Early Stage Collaborative.
INNOVATION DURHAM NORTHUMBERLAND (IDN) March 3, 2011.
Advancing Alternative Energy Technologies Glenn MacDonell Director, Energy Industry Canada Workshop on Alternatives to Conventional Generation Technologies.
Technology and Economic Development Intellectual Property Issues in Research Jim Baker Director Office of Technology and Economic Development
IP Issues in Research Jim Baker, Executive Director Innovation, and Industry Engagement.
Towards Better Exploitation and Economic Impact: Developing the EPSRC Partnership with the University Vince Osgood Associate Director, Economic Impact.
Helping Small Medium Enterprises (SMEs) grow through innovation
“IP Universities” Istanbul, May 16 to 18, 2012 Albert Long Hall, BOGAZICI UNIVERSITY Knowledge Management and IP M Mr. Gary N. Keller, MsB,
Talent First: opportunity to collaborate with Federal Labs Tony Bailetti Director, Talent First Director, Technology Innovation Management program (
Introduction Breadth How it Works The Next Steps.
AusIndustry Martin Cebis AusIndustry – Entrepreneur Development Facilitator.
New Academic Staff Orientation: Research Fall 2014.
Growing open source businesses in the National Capital Region Barcamp Ottawa 3 Saturday March 31 Tony Bailetti
Vilnius Lithuania BSc.: Biochemistry Neuropsychology J.D.: University of Oregon LL.M.:University College London Pacific Northwest National Laboratory.
Innovations at U of T the business of ideas Presentation to the Institute for Optical Sciences December 1 st, 2006 Dr. Cyril Gibbons Director, Commercialization.
SMEs Division National IP Action Plan for Entrepreneurs and SMEs March 2008 Small and Medium-Sized Enterprises Division World Intellectual Property Organization.
GATEWAY TO FINNISH EXPERTISE 1 Commercialization guidelines – NanoCom and ProNano results Dr. Eeva Viinikka, Business Director Programme Director of National.
CANADA – EUROPE Partners in the world / Partenaires dans le monde S&T Information Day: Scientific Cooperation with the EU Budapest 27 March 2007 Patricia.
Management of Intellectual Property at Iowa State University Contributing to Economic Development Kenneth Kirkland, Ph.D. Executive Director, Iowa State.
John McDougall, President 10 th Annual Re$earch Money Conference, 11 May 2011.
Commercialization Success and Failure The Waterloo Experience Panel 2: Public Funding and Innovation in Post-Secondary Institutions.
The Interface between Universities Public Research Institutions and SMEs Training of Trainer’s Program, Teheran 10 June 2015 By Matthias Kuhn, MBA University.
Photo by hernandezfisher - Creative Commons Attribution-NonCommercial-ShareAlike License with Haiku.
George McAllister ext The SBTDC is a business advisory service of The University of North Carolina System operated.
September 5, 2013 Growing Missouri’s Economy Through Innovation and Entrepreneurship.
Innovation Systems Research Network MCRI Theme III: Social Inclusion and Civic Engagement David A. Wolfe, Ph.D. Program on Globalization and Regional Innovation.
Advisory Board and Commission Retreat September 11-12, 2013.
NEW INNOVATION SUPPORT SERVICES, case Finland Mervi Käki, CEO, Partner
Finance Wales Investing in life sciences. Who are we?  The Finance Wales Group comprises:  Finance Wales  FW Capital, our non Welsh fund management.
May 29, Missouri Technology Corporation  Public-private partnership created by the Missouri General Assembly to lead efforts to promote entrepreneurship.
Page 1 New Models for Commercialization Federal Partners in Technology Transfer June 18, 2009 A presentation by: Tom Corr Chief Executive Officer Accelerator.
CRUI - WIPO Training Programme on intellectual property and management of innovation in small and medium-sized enterprises, Universities, Spin off and.
Venturing Forth: Private Equity Funds in Namibia By Robin Sherbourne Director of the Institute for Public Policy Research 14 May 2003.
© PEP 2005 All rights reserved “Connecting the Dots… from Researcher to Market” Harvesting the value of innovation Courtney Price, Ph.D.
Moving MAT Products from Innovation to Invoice OCN and Federal Labs Meeting December 12, 2006 Jennifer Woods.
A new start for the Lisbon Strategy Knowledge and innovation for growth.
October 5, 2004FPTT 2004 TechExpo1 Ideas vs Intellectual Property: The Carleton University Technology Transfer Approach: “Building True Innovation Capacity.
7 th Annual ISRN National Conference Gerry Cooper Director, innovation Industry Canada May 5, 2005 Session II: Ontario ICT Clusters.
OCN and Federal Labs Initiative “Building Industry Receptor Capacity” Ontario Commercialization Network/Federal Partners In Technology Session Ottawa,
Rural Development Council 8 th December Contents Scottish Enterprise Focus Economic Downturn Implications & Actions Core Rural Objectives HIE Economic.
11-1 Copyright © 2010 Pearson Education, Inc. publishing as Prentice Hall Part IV: Start-up Financial Strategy Chapter 11: Funding the Technology Start-up.
VED S.A.. VED Your trusted partner for Investment Management, Mergers & Acquisitions and Real Estate Investments VED S.A. 1.
JUMPSTART NEW JERSEY ANGEL NETWORK Presentation at Pathway to Equity Financing Conference by Wayne Tamarelli, PhD Held by New Jersey.
FLC Northeast Conference September 10, 2014 NECEC Institute Cleantech Open NE & Fraunhofer CSE.
ONTARIO CENTRES OF EXCELLENCE Briefing for the York Boot Camp July 19, 2012.
Meet the Investors Sheffield Hallam University Tuesday 4 th March 2008.
Project Name Project Proposal Presentation to the Virginia Biosciences Health Research Corporation Project Management and Oversight Panel Presentation.
Indiana University Professional Opportunities Orientation Program September 17, 2002 Presented by: Brian Oliver Jeff Brown Financial Opportunities.
© PEP 2005 All rights reserved “Business Development Programs & Tools ” Harvesting the Value of Innovation Courtney Price, Ph.D.
Canada: Challenges and Models for Biotechnological Innovation. Tania M. Bubela, BSc, PhD, LLB School of Business, University of Alberta and the Centre.
 Updated – Separated - Linked  One-stop business consulting.
Building Meaningful Collaborations Between OCN and Federal Labs in Ontario Ottawa RIDP Stephen Daze
Enabling Building Efficiency: The NYC Urban Technology Innovation Center TIMOTHY CROSS, COLUMBIA ENGINEERING IEEE INNOVATION DAY POLYTECHNIC INSTITUTE.
SMALL PRESENTATION ON THREE BIG IDEAS Strategic Planning Retreat 6/2011.
OTC FELLOWS PROGRAM INFORMATION SESSION Fall 2016.
With thanks to our sponsor
Technology Transfer Office
[Project Title] [Presentation Date]
Five Steps To Effective Research Proposals
[Project Title] [Presentation Date]
Towards a roadmap for collaborative R&D
Matt Grattan Director, Community & Economic Development University at Albany.
Commercialization Strategies
Gestora brasileiro focada exclusivamente na área da saúde.
Lockheed Martin Canada’s SMB Mentoring Program
[Project Title] [Presentation Date]
Application and Presentation to the
OUR HISTORY & MISSION ABOUT US. OUR HISTORY & MISSION ABOUT US.
Presentation transcript:

Golden Horseshoe Bioscience Network – Solutions for Life Golden Horseshoe Biosciences Network – Solutions for Life Darlene Homonko, PhD Executive Director Commercialization of Innovative Research: Implementing Solutions that Work for Canada Osgoode Hall,York University Toronto ON Thoughts for Successful Commercialization March 20, 2009

Golden Horseshoe Bioscience Network – Solutions for Life Partners in a Regional Innovation Initiative Network of business leaders, researchers, entrepreneurs, and economic development officers involved in biosciences, biotechnology, and related fields Industry Academic Institutions Health Sciences Centres & Hospitals Federal & Provincial Government Business Support Services Other Regions & Consortia Municipal Governments GHBN

Golden Horseshoe Bioscience Network – Solutions for Life Fundamentals 1.Assets 2.Opportunity 3.Resources

Golden Horseshoe Bioscience Network – Solutions for Life Cultures with Different Values Academia Publish Research Share information Answer to public Inclusive Driven by ideas Time insensitive Industry Patent Development Secretive Answer to shareholders Exclusive Driven by markets Time sensitive

Golden Horseshoe Bioscience Network – Solutions for Life Currency for Commercialization Research outcomes that produce value - Intellectual Assets –Patents –Copyrights –Trademarks –Know How

Golden Horseshoe Bioscience Network – Solutions for Life The Opportunity 3 Fundamental ‘Value Drivers’ - Competitive Product Advantage/ Markets Technology/IP opportunities Management

Golden Horseshoe Bioscience Network – Solutions for Life The First Steps Find people you can trust with business expertise Confidential Disclosure –written Non-Disclosure Agreement (NDA) Recommendations and referrals from credible sources Network

Golden Horseshoe Bioscience Network – Solutions for Life The First Steps (cont’d) Draw a roadmap – Development plan – Account for risks Set milestones Generate a business plan Know the market and the competition Advisory Boards with experience Board of Directors – Good governance starts day 1

Golden Horseshoe Bioscience Network – Solutions for Life Keys to Early Stage Success Orientation to products, markets and partners Focus on scientific milestones Patent strategy Operationally sound development plan Management Founders need to be engaged Commercial expertise Create value at every development stage

Golden Horseshoe Bioscience Network – Solutions for Life What does “creating value” mean? Data - validating the technology opportunity IP portfolio –dominant patent position –In-licensing Business or Development Plan –Execute Attracting ‘capital’ to continue development plan at a reasonable valuation Capturing value through partnerships

Golden Horseshoe Bioscience Network – Solutions for Life ‘Creating Value’ at the Early Stage Product - performs better & meets a need Vision for opportunity IP - Strong world-wide with freedom to operate Markets - Large and sufficient to repay major investments R&D Plan - Defined developmental milestones Manufacturing - practical and cost effective Structure matches opportunity - license vs. company Valuation – reasonable; keeping in mind next investor

Golden Horseshoe Bioscience Network – Solutions for Life Synergies to Build Value Valuation lllllll l llll l Discovery Pre-clinical Development Clinical Phase I Phase II Phase III years

Golden Horseshoe Bioscience Network – Solutions for Life Synergies to Build Value Valuation llllllllll l ll Research Pre-clinical Development Clinical Phase I Phase II Phase III years Market/Commercial Clinical Partnerships Vision - First Investment Technology - IP Development Plan Financial Plan

Golden Horseshoe Bioscience Network – Solutions for Life Typical Stage Valuations Valuation llllllll l lll l Research Pre-clinical Development Clinical Phase I Phase II Phase III years VAL: $500MM TIME: 2-5yrs 2yrs 5-7yrs 5 yrs WHO: UNIV. Start-up Partner Pharma

Golden Horseshoe Bioscience Network – Solutions for Life Issues Affecting Successful Commercialization Technology or Intellectual Property 38% Economics/ROI 35% Market 27%

Golden Horseshoe Bioscience Network – Solutions for Life Resources Networks RINs (GHBN), MaRS, HTX, MaRSLanding, Innovatech, BitNet, GHVF, TVG, NAO, OCRI…. Industry organizations Regional and Provincial economic development depts. –Small business enterprise centres Federal – Industry Canada, DFAIT etc. ORCIP

Golden Horseshoe Bioscience Network – Solutions for Life Government Funding Sources Ontario Research Commercialization Program (ORCP) –C4 POP Fund Ontario Commercialization Investment Funds (OCIF) Ontario Centre of Excellence (OCE) Networks of Centre of Excellence (NCE) Canadian Foundation for Innovation (CFI) Canadian Institute of Health Research (CIHR) - POP program National Science and Engineering Research Council (NSERC) - I2I program Ontario Genomics Institute (OGI)/Genome Canada

Golden Horseshoe Bioscience Network – Solutions for Life ON MRI Commercialization Programs 17 M Business Mentorship and Entrepreneurship Program 29 M Investment Accelerator Fund 24 M Innovation Demonstration Fund 90 M Risk Capital Fund

Golden Horseshoe Bioscience Network – Solutions for Life Government Resources (cont’d) SR & ED Tax Credits IRAP TPC funds Industry Sector specific Grants –Environment, Energy, Agriculture

Golden Horseshoe Bioscience Network – Solutions for Life Resources (cont’d) Venture capital Angel money Traditional Bank Financing Debt Financing Public Markets CPC Private or Public Corporation Investment Funds Microsoft, Johnson and Johnson, Dupont, Kirin etc.

Golden Horseshoe Bioscience Network – Solutions for Life Commercialization Support Business plans, Commercial strategy Link to MaRS for venture services –Evaluation & market research Access to capital Primary link in identifying government programs and resources Linkages to regional, national and international partners and investors Active business development and marketing Business mentors Work in partnership with ORCIP, other networks

Golden Horseshoe Bioscience Network – Solutions for Life Golden Horseshoe Biosciences Network – Solutions for Life Darlene Homonko, PhD Executive Director Darlene Homonko, PhD